|
|
|
|
|
|
|
|
JAMA | JAMA Network
Advocates of pharmacogenomics say the field is an emerging resource for improving patient safety. Since 2012, more than 1 million adverse drug events have been reported each year to the US Food and Drug Administration (FDA), “many of which might be preventable using PGx testing,” Geoffrey S. Ginsburg, MD, PhD, director of the Center for Applied Genomics and Precision Medicine at Duke University Medical Center, said in an email.
Patient Version
Clinicians
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.